Lapisteride: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
CSV import
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
'''Lapisteride''' is a [[pharmaceutical drug]] used in the treatment of [[benign prostatic hyperplasia]] (BPH) and [[androgenetic alopecia]] (male pattern baldness). It is a [[5α-reductase inhibitor]], a class of drugs that inhibit the conversion of [[testosterone]] to [[dihydrotestosterone]] (DHT).
{{Short description|Overview of the drug Lapisteride}}
{{Drugbox
| verifiedfields = changed
| verifiedrevid = 123456789
| image = Lapisteride.png
| image_size = 200px
| image_alt = Chemical structure of Lapisteride
| image_caption = Chemical structure of Lapisteride
}}


== Mechanism of Action ==
'''Lapisteride''' is a pharmaceutical compound that functions as a [[5-alpha-reductase inhibitor]]. It is primarily used in the treatment of conditions related to [[androgen]]s, such as [[benign prostatic hyperplasia]] (BPH) and [[androgenic alopecia]].


Lapisteride works by inhibiting the enzyme [[-reductase]], which is responsible for the conversion of testosterone to DHT. DHT is a potent androgen that stimulates the growth of prostate cells and hair follicles. By reducing the levels of DHT, lapisteride can help to shrink an enlarged prostate and slow down or stop hair loss.
==Mechanism of Action==
Lapisteride works by inhibiting the enzyme [[5-alpha-reductase]], which is responsible for the conversion of [[testosterone]] into [[dihydrotestosterone]] (DHT). DHT is a potent androgen that plays a significant role in the development and progression of BPH and androgenic alopecia. By reducing the levels of DHT, Lapisteride helps in alleviating the symptoms associated with these conditions.


== Uses ==
==Clinical Uses==
Lapisteride is primarily indicated for the treatment of:


=== Benign Prostatic Hyperplasia ===
* [[Benign prostatic hyperplasia]]: It helps in reducing the size of the enlarged prostate, thereby improving urinary flow and reducing the risk of urinary retention.
* [[Androgenic alopecia]]: It is used to slow down hair loss and promote hair regrowth in individuals with male pattern baldness.


Lapisteride is used in the treatment of BPH, a common condition in older men where the prostate gland becomes enlarged. This can cause problems with urination, such as a weak stream or the need to urinate frequently. By reducing the size of the prostate, lapisteride can help to alleviate these symptoms.
==Side Effects==
Common side effects of Lapisteride include:


=== Androgenetic Alopecia ===
* Decreased libido
* Erectile dysfunction
* Ejaculation disorders


Lapisteride is also used to treat androgenetic alopecia, a common form of hair loss in men. By inhibiting the action of DHT on hair follicles, lapisteride can help to slow down or stop hair loss and in some cases, promote hair regrowth.
These side effects are generally mild and tend to resolve with continued use of the medication.


== Side Effects ==
==Pharmacokinetics==
Lapisteride is well absorbed after oral administration. It undergoes extensive hepatic metabolism and is primarily excreted in the urine. The half-life of Lapisteride allows for once-daily dosing, which enhances patient compliance.


Like all drugs, lapisteride can cause side effects. These may include decreased libido, erectile dysfunction, and ejaculation disorders. In rare cases, it can also cause breast enlargement and tenderness.
==Contraindications==
Lapisteride is contraindicated in:


== See Also ==
* Women who are or may become pregnant, due to the risk of fetal harm.
* Patients with known hypersensitivity to the drug or any of its components.


* [[-reductase inhibitor]]
==Related pages==
* [[5-alpha-reductase inhibitor]]
* [[Benign prostatic hyperplasia]]
* [[Benign prostatic hyperplasia]]
* [[Androgenetic alopecia]]
* [[Androgenic alopecia]]
* [[Dihydrotestosterone]]


[[Category:Pharmaceutical drugs]]
[[Category:5-alpha-reductase inhibitors]]
[[Category:5α-reductase inhibitors]]
[[Category:Drugs used in benign prostatic hyperplasia]]
[[Category:Benign prostatic hyperplasia]]
[[Category:Hair loss medications]]
[[Category:Androgenetic alopecia]]
 
{{Pharma-stub}}
{{No image}}
<gallery>
File:Lapisteride.png|Lapisteride
</gallery>

Latest revision as of 18:48, 23 March 2025

Overview of the drug Lapisteride


Lapisteride
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG


Lapisteride is a pharmaceutical compound that functions as a 5-alpha-reductase inhibitor. It is primarily used in the treatment of conditions related to androgens, such as benign prostatic hyperplasia (BPH) and androgenic alopecia.

Mechanism of Action[edit]

Lapisteride works by inhibiting the enzyme 5-alpha-reductase, which is responsible for the conversion of testosterone into dihydrotestosterone (DHT). DHT is a potent androgen that plays a significant role in the development and progression of BPH and androgenic alopecia. By reducing the levels of DHT, Lapisteride helps in alleviating the symptoms associated with these conditions.

Clinical Uses[edit]

Lapisteride is primarily indicated for the treatment of:

  • Benign prostatic hyperplasia: It helps in reducing the size of the enlarged prostate, thereby improving urinary flow and reducing the risk of urinary retention.
  • Androgenic alopecia: It is used to slow down hair loss and promote hair regrowth in individuals with male pattern baldness.

Side Effects[edit]

Common side effects of Lapisteride include:

  • Decreased libido
  • Erectile dysfunction
  • Ejaculation disorders

These side effects are generally mild and tend to resolve with continued use of the medication.

Pharmacokinetics[edit]

Lapisteride is well absorbed after oral administration. It undergoes extensive hepatic metabolism and is primarily excreted in the urine. The half-life of Lapisteride allows for once-daily dosing, which enhances patient compliance.

Contraindications[edit]

Lapisteride is contraindicated in:

  • Women who are or may become pregnant, due to the risk of fetal harm.
  • Patients with known hypersensitivity to the drug or any of its components.

Related pages[edit]